Browse studies

Find your next paid study

6 recruiting studies matching your filters

Early Detection of Pancreatic Cancer: Prospective Study

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more

Estimated

~$10 – $750

City of Hope Medical CenterNCT06388967

Observational

Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer

The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients w…

Pancreatic CancerLiver Cancer (Locally Advanced or Metastatic)Pancreatic Cancer Non-resectable+6 more

Estimated

~$10 – $7,500

Banner HealthNCT07817147

Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device

This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.

Pancreatic Fluid CollectionsBiliary ObstructionPancreatic Duct Obstruction+2 more

Estimated

~$10 – $1,050

Orlando Health, Inc.NCT07696572

Phase 2

A Randomized Phase II Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Advanced Pancreatic and Colorectal Cancer (CanPan-C)

Many patients with advanced pancreatic cancer and colorectal cancer experience burdensome and difficult-to-treat symptoms. The impact of multiple symptoms (cal…

Pancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic

Estimated

~$10 – $7,500

HealthPartners InstituteNCT06605430

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System

The purpose of this study is to evaluate the short and intermediate term safety of the NanoKnife Irreversible Electroporation System when used off-label to tre…

Pancreatic Cancer Non-resectable

Estimated

~$10 – $750

Englewood Hospital and Medical CenterNCT06937996

Phase 2

Impact of Tumor and Stromal Subtypes on Efficacy of Neoadjuvant FOLFIRINOX in Subjects With Non-Metastatic Pancreatic Cancer

This is a research study to evaluate how the genetic makeup of Pancreatic Ductal Adenocarcinoma (PDAC) can affect the response to FDA-approved chemotherapy tre…

Pancreatic Ductal Adenocarcinoma (PDAC)Cancer of PancreasPancreatic Cancer, Adult+4 more

Estimated

~$10 – $6,250

UNC Lineberger Comprehensive Cancer CenterNCT03977233